Sort
172,184 grants matching “inflammation”
Immunocompatible electronic polymers and devices for implantable sensors and stimulators that resist foreign-body responses
$984,000Sihong Wang · University Of Chicago · DP2 · FY2025 · EB
Genome Editing Testing Core
$983,875David J Segal · University Of California At Davis · U42 · FY2021 · OD
THERAPEUTIC USE OF INTER-ALPHA INHIBITOR IN SEPSIS
$983,869Yow-Pin Lim · Prothera Biologics, Llc · R44 · FY2007 · GM
University of Michigan Center for Gastrointestinal Research
$983,685John W Wiley · University Of Michigan At Ann Arbor · P30 · FY2021 · DK
NAAA Inhibition for Pain and Inflammation
$983,494Edward Paul Monaghan · Neokera, Llc · R44 · FY2018 · NS
Epigenomic Biomarkers of HIV-Associated Cancers in Nigeria
$983,472Lifang Hou · Northwestern University At Chicago · U54 · FY2019 · CA
Studies of Rare Cancers
$983,415Louise Brinton · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Evaluation and treatment of drug-resistant epilepsy
$983,315William Theodore · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based assay to reveal novel T cell subsets in SARS-CoV-2 infected patients
$983,246Jonathan D Powell · Johns Hopkins University · U54 · FY2020 · CA
Novel Strategies Targeting Acute Exacerbation of COPD
$982,969Richard K Albert · Denver Health And Hospital Authority · U10 · FY2007 · HL
Aminergic Function in Aging and Alzheimers Disease
$982,923University Of South Florida · P01 · FY2002 · AG
Thromboregulatory strategies to prolong xenograft survival.
$982,867Simon C Robson · Beth Israel Deaconess Medical Center · U01 · FY2009 · AI
A Precision Medicine for Alcohol-Associated Liver Disease
$982,659Wanqing Liu · Genetobe Inc. · UT2 · FY2024 · AA
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
$982,509Martin Devenport · Oncoimmune, Inc. · R44 · FY2018 · CA
Broadly neutralizing(BN) pan-IgE supersite vaccine for allergic asthma
$982,439Swey-Shen Chen · Ige Therapeutics, Inc. · R44 · FY2019 · AI
Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease
$982,403Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2018 · MH
Mucins and immune cell interactions in ovarian cancer pathogenesis & progression
$982,295Daniel William Cramer · Brigham And Women'S Hospital · R35 · FY2019 · CA
1/2 Mechanisms of alcohol pathology: a collaborative partnership between NCCU and UNC
$982,262Gregory Jay Cole · North Carolina Central University · U54 · FY2019 · AA
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$982,140Dorothy Anne Cross · Washington University · P01 · FY2011 · NS
Translational Research Center for Expedite Novel Therapies in Cystic Fibrosis
$982,095Bonnie W Ramsey · Seattle Children'S Hospital · P30 · FY2010 · DK
HIP fracture Accelerated surgical TreaTment And Care tracK-2 (HIP ATTACK-2) trial
$982,071Gerard Slobogean · University Of Maryland Baltimore · U01 · FY2023 · AR
SHARED RESOURCE ANIMAL HEALTH
$982,058Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2009 · CA
Characterization of the molecular mechanisms of LC3-associated phagocytosis and its role in disease pathogenesis
$982,000Jennifer Martinez · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
AsthmaNet: Brigham and Women's Hospital & Children's Hospital Boston
$981,959Elliot Israel · Brigham And Women'S Hospital · U10 · FY2010 · HL
SBIR Phase II: A Novel Platform to Enable Directed Delivery of Therapeutics into Brain Injuries
$981,925Sazid Hussain · Aivocode · · FY2017 · TIP